Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

RPHM Reneo Pharmaceuticals Inc

1,6915

0,0315 (1,90%)

Nach Börsenschluss

Zuletzt aktualisiert: 23:46:23

Verzögert um 15 Minuten

Form EFFECT - Notice of Effectiveness

Reneo Pharmaceuticals (NASDAQ:RPHM)
Historical Stock Chart
Von Apr 2024 bis Mai 2024

Click Here for more Reneo Pharmaceuticals Charts.

Reneo Pharmaceuticals (NASDAQ:RPHM)
Historical Stock Chart
Von Mai 2023 bis Mai 2024

Click Here for more Reneo Pharmaceuticals Charts.

News Reneo Pharmaceuticals Inc

Form 425 - Prospectuses and communications, business combinations
Montag 13 Mai 2024 (4 Tage vor) • Edgar (US Regulatory)

Form 8-K - Current report
Montag 13 Mai 2024 (4 Tage vor) • Edgar (US Regulatory)

Reneo Pharmaceuticals and OnKure Announce Proposed Merger
Montag 13 Mai 2024 (4 Tage vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dienstag 7 Mai 2024 (1 Woche vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 7 Mai 2024 (1 Woche vor) • Edgar (US Regulatory)

Reneo Pharmaceuticals Reports First Quarter 2024 Financial Results
Dienstag 7 Mai 2024 (1 Woche vor) • GlobeNewswire Inc.

Reneo Pharmaceuticals Reports Fourth Quarter And Full Year 2023 Financial Results And Business Update
Donnerstag 28 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Sagimet Biosciences Announces Appointment of Tim Walbert and Paul Hoelscher to its Board of Directors
Montag 25 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Freitag 23 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Montag 5 Februar 2024 (3 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 14 Dezember 2023 (5 Monate vor) • Edgar (US Regulatory)

Reneo Pharmaceuticals Announces Results from Pivotal STRIDE Study of Mavodelpar in Primary Mitochondrial Myopathies (PMM)
Donnerstag 14 Dezember 2023 (5 Monate vor) • GlobeNewswire Inc.

Weitere Reneo Pharmaceuticals Inc News-Artikel

Vontobel Financial Produ...

Tidewater Inc. New

Capital Partners

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen